Evidence map›Paper›PMID 35052632›Full record

ArticleAntioxidants (Basel, Switzerland)2022

Activity-Dependent Neuroprotective Protein (ADNP)-Derived Peptide (NAP) Counteracts UV-B Radiation-Induced ROS Formation in Corneal Epithelium.

Grazia Maugeri, Agata Grazia D'Amico, Salvatore Giunta, Cesarina Giallongo, Daniele Tibullo, Claudio Bucolo, Salvatore Saccone, Concetta Federico, Davide Scollo, Antonio Longo and 3 more

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Grazia MaugeriSection of Anatomy, Histology and Movement Sciences, Department of Biomedical and Biotechnological Sciences, University of Catania, 95100 Catania, Italy.ORCID 0000-0003-0173-4885
Agata Grazia D'AmicoDepartment of Drug Sciences, University of Catania, 95125 Catania, Italy.
Salvatore GiuntaSection of Anatomy, Histology and Movement Sciences, Department of Biomedical and Biotechnological Sciences, University of Catania, 95100 Catania, Italy.ORCID 0000-0002-8095-8678
Cesarina GiallongoDepartment of Medical, Surgical Sciences and Advanced Technologies G.F. Ingrassia, University of Catania, 95123 Catania, Italy.
Daniele TibulloDepartment of Biomedical and Biotechnological Sciences, Section of Biochemistry, University of Catania, 95123 Catania, Italy.ORCID 0000-0002-4416-8556
Claudio BucoloPharmacology Section, Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy.
Salvatore SacconeSection of Animal Biology, Department of Biological, Geological and Environmental Sciences, University of Catania, 95123 Catania, Italy.ORCID 0000-0001-7568-5823
Concetta FedericoSection of Animal Biology, Department of Biological, Geological and Environmental Sciences, University of Catania, 95123 Catania, Italy.ORCID 0000-0002-0160-9040
Davide ScolloDepartment of Ophthalmology, Eye Clinic, University of Catania, 95123 Catania, Italy.
Antonio LongoCenter for Research in Ocular Pharmacology (CERFO), University of Catania, 95123 Catania, Italy.
Teresio AvitabileCenter for Research in Ocular Pharmacology (CERFO), University of Catania, 95123 Catania, Italy.
Giuseppe MusumeciSection of Anatomy, Histology and Movement Sciences, Department of Biomedical and Biotechnological Sciences, University of Catania, 95100 Catania, Italy.ORCID 0000-0002-8260-8890
Velia D'AgataSection of Anatomy, Histology and Movement Sciences, Department of Biomedical and Biotechnological Sciences, University of Catania, 95100 Catania, Italy.ORCID 0000-0003-1114-8265
University of Catania · IT

Funding

PIAno di inCEntivi per la RIcerca di Ateneo 2020/2022 Linea di Intervento 2 "Nanoret". NanoretPIAno di inCEntivi per la RIcerca di Ateneo 2020/2022 Linea di Intervento 3 "Starting Grant" 2021-UNCTCLE-0830801 "REPAIR" UNCTCLE-0830801
6 · The paper itself

Abstract

The corneal epithelium, the outermost layer of the cornea, acts as a dynamic barrier preventing access to harmful agents into the intraocular space. It is subjected daily to different insults, and ultraviolet B (UV-B) irradiation represents one of the main causes of injury. In our previous study, we demonstrated the beneficial effects of pituitary adenylate cyclase-activating polypeptide (PACAP) against UV-B radiation damage in the human corneal endothelium. Some of its effects are mediated through the activation of the intracellular factor, known as the activity-dependent protein (ADNP). In the present paper, we have investigated the role of ADNP and the small peptide derived from ADNP, known as NAP, in the corneal epithelium. Here, we have demonstrated, for the first time, ADNP expression in human and rabbit corneal epithelium as well as its protective effect by treating the corneal epithelial cells exposed to UV-B radiations with NAP. Our results showed that NAP treatment prevents ROS formation by reducing UV-B-irradiation-induced apoptotic cell death and JNK signalling pathway activation. Further investigations are needed to deeply investigate the possible therapeutic use of NAP to counteract corneal UV-B damage.

Indexed as

ADNPapoptosiscorneal epitheliumNAPROSUV-B

Identifiers

PMID35052632
PMCPMC8773440
OpenAlexW4205482119

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.